Abby Care Raises $82 Million Series C to Pay Family Caregivers

By Olivia Hart

Abby Care has raised an $82 million Series C to turn parents and relatives into certified, paid caregivers for medically complex patients. Transformation Capital led the round, Fortune first reported. New money came from CVS Health Ventures, Frist Cressey Ventures and Pivotal Ventures; existing investors Khosla Ventures, Thrive Capital and Sequoia doubled their positions.

The company, founded by Havi Nguyen in 2022, operates as a Medicaid provider. It trains family members to become certified caregivers, pays them, and supports them afterward. Nguyen's framing of the model is direct.

"The question I kept asking myself was: Who's that one person in the child's life who's not going to turn away, and is able to be with them to deliver that care?" Nguyen said. "Parents were always willing to raise their hand and step up."

The pitch rests on arithmetic as much as sentiment. Justin Brock, general partner at CVS Health Ventures, pointed to a gap the industry has not closed.

"A traditional private duty nurse program only fills 65% of authorized shifts, which is crazy," Brock told Fortune. "It's really leaving so many medically complex members without consistent coverage… [Meanwhile] you have these tens of millions of family caregivers who are in the home, and a lot of them are already doing care."

Who is the founder, and why does it matter?

Nguyen's credentials come from lived experience, not just a spreadsheet. As the eldest daughter in a family that had recently immigrated from Vietnam, she missed school as a child to translate at doctors' appointments and managed the family's Medicaid paperwork. At 21, she joined an early-stage health tech startup focused on therapy for children with autism, during the depths of COVID. There she watched therapists and technicians cycle rapidly from one gig to another.

"Could we design a care model where the person who wants to deliver care to the patient is already with them?" Nguyen asked herself. Abby Care became the answer.

Her claim about what wins in this market is expansive, and untested at the scale the Series C implies.

"The companies that are really going to be able to succeed are companies that can think about designing the care model that brings all the stakeholders and the U.S. health care system together," Nguyen said.

That is a promise, not a result. The company disclosed no revenue, valuation, or patient-count figures alongside the raise.

What does the money buy families?

The model's appeal shows up in cases like Maria Villegas Corrales, a Colorado mother whose daughter Mia was born with serious medical complexities requiring open heart surgery and a pacemaker in her first years. Corrales found Abby Care after Mia's surgery in June 2024. Her description of standard discharge practice is blunt.

"Sometimes they just give you a little bag to go home and figure it out," Corrales said. "It's scary to go home and not be able to know what's to be expected. And a lot of times it's just learning on the run."

She said becoming a paid caregiver allowed her to be the best mother possible to Mia. She added that awareness, not eligibility, is the bottleneck: "Families can have the resources to be paid to care for their child, that's number one, because a lot of people don't know about this."

One family's testimony, however, is not an outcomes study. The source material offers no data on caregiver retention, patient results, or Medicaid cost savings.

How crowded is the field?

Brock acknowledged competition without naming a market leader. Possible rivals range from existing home health agencies to caregiver education platforms. His argument is that the need simply outweighs the field: tens of millions of family caregivers already deliver unpaid care at home, while agencies leave roughly one in three authorized nursing shifts unfilled.

Nguyen frames the commitment as long-term rather than transactional.

"I always tell the team this: Abby Care isn't just here to empower and pay family caregivers," she said. "We're ultimately here to make them feel like they can thrive and succeed."

The $82 million now gives that thesis room to be tested. Whether an AI-native startup can hold together patients, regulators, health plans and paid family members at Medicaid rates is the question the next funding cycle will answer.